Skip to main content
VCbacked
Log inGet Started

NRG Therapeutics

Cambridge, United Kingdom

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

$67.5M raised
Sep 2025
Series B
BiopharmaBiotechnologyHealth CareNeurosciencePharmaceutical

Top Investors

British Business BankBrandon CapitalOmega FundsDementia Discovery FundMichael J. Fox Foundation

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NRG Therapeutics

How much funding has NRG Therapeutics raised?
NRG Therapeutics has raised $67.5M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
Who are NRG Therapeutics's investors?
NRG Therapeutics's investors include British Business Bank, Brandon Capital, Omega Funds, Dementia Discovery Fund, Michael J. Fox Foundation.
Where is NRG Therapeutics headquartered?
NRG Therapeutics is headquartered in Cambridge, United Kingdom.
What does NRG Therapeutics do?
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
What stage is NRG Therapeutics at?
NRG Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NRG Therapeutics — Funding & Investors." VCBacked, September 8, 2025, https://www.vcbacked.co/company/nrg-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). NRG Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nrg-therapeutics
Wikipedia (cite web)
{{cite web |title=NRG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nrg-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego